Cdk7 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdk7 monoclonal antibodies for research in cell cycle regulation and transcriptional control. Cdk7 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdk7, a cyclin-dependent kinase, plays a crucial role in the phosphorylation of the C-terminal domain of RNA polymerase II, facilitating the transition from transcription initiation to elongation. Additionally, Cdk7 is involved in the regulation of cell cycle progression and has been implicated in various cellular processes, making it a significant target for cancer research. Understanding the function of Cdk7 is essential for elucidating the mechanisms of cell proliferation and differentiation. Researchers can explore the complex interactions between Cdk7 and its substrates using specific detection methods. Investigating Cdk7's role in transcriptional regulation provides valuable insights into gene expression control mechanisms. The relationship between Cdk7 and cell cycle checkpoints continues to be an active area of scientific investigation. Santa Cruz Biotechnology monoclonal antibodies for Cdk7 support researchers worldwide in advancing our understanding of cellular regulation and potential therapeutic applications.